DEF 14AThe Ballot
Ultragenyx Pharmaceutical Inc. files DEF 14A
Filed Mar 28, 2025 · 1y ago · Accession 0001308179-25-000296
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Ticker
- RARE
- CIK
- 1515673
- Form type
- DEF 14A
- Filing date
- Mar 28, 2025
- Report date
- May 15, 2025
- Document
- rare013868-def14a.htm
- Size
- 14.5 MB